skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Mosaic has reported improved revenue, EBITDA, FCF and Payout Ratio vs Y2018, and the share price has responded positively. Looking past EBITDA, however, I see that income has not just declined but reversed; what is it about the former metrics that leads the market to ignore the latter? Is the idea, here, that income will go up and down as the company makes investments , but as long as the company is growing then per-year income doesn't matter so much?
Read Answer Asked by John on May 17, 2019
Q: I would appreciate your analysis of their latest results. The market seems to have yawned in reaction. Thanks as always.

Revenue Increase of 32.6% and Adjusted EBITDA Increase of 143%
--------------------------------------------------------------------
Revenue for the first quarter ended March 31, 2019 was $39.0 million, an increase of $9.6 million over the prior year period.

Gross profit grew to $14.3 million in the first quarter of 2019, compared to $10.6 million in the first quarter of 2018.

Adjusted EBITDA(2) was $3.5 million in the first quarter of 2019, compared to $1.4 million in the first quarter of 2018.

Investor Conference Call on May 14, 2019 at 8:00 a.m. ET
Read Answer Asked by karl on May 15, 2019
Q: I have some cash to add to a small growth , non-registered portfolio, holding TSGI, SYz, COV . Looking at MCR or PHO . Would you recommend either of these or would you suggest an alternative. Or would you prefer just adding to one of the 3 existing ones.
Many thanks as always.
Read Answer Asked by Alexandra on May 15, 2019